 Cognitive Dysfunction
"Cognitive Dysfunction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished or impaired mental and/or intellectual function.
| Descriptor ID |
D060825
|
| MeSH Number(s) |
F03.615.250.700
|
| Concept/Terms |
Cognitive Dysfunction- Cognitive Dysfunction
- Cognitive Dysfunctions
- Dysfunction, Cognitive
- Dysfunctions, Cognitive
- Cognitive Impairments
- Cognitive Impairment
- Impairment, Cognitive
- Impairments, Cognitive
Mild Cognitive Impairment- Mild Cognitive Impairment
- Cognitive Impairment, Mild
- Cognitive Impairments, Mild
- Impairment, Mild Cognitive
- Impairments, Mild Cognitive
- Mild Cognitive Impairments
- Mild Neurocognitive Disorder
- Disorder, Mild Neurocognitive
- Disorders, Mild Neurocognitive
- Mild Neurocognitive Disorders
- Neurocognitive Disorder, Mild
- Neurocognitive Disorders, Mild
Cognitive Decline- Cognitive Decline
- Cognitive Declines
- Decline, Cognitive
- Declines, Cognitive
- Mental Deterioration
- Deterioration, Mental
- Deteriorations, Mental
- Mental Deteriorations
|
Below are MeSH descriptors whose meaning is more general than "Cognitive Dysfunction".
Below are MeSH descriptors whose meaning is more specific than "Cognitive Dysfunction".
This graph shows the total number of publications written about "Cognitive Dysfunction" by people in this website by year, and whether "Cognitive Dysfunction" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 3 | 0 | 3 | | 2012 | 3 | 1 | 4 | | 2013 | 7 | 0 | 7 | | 2014 | 3 | 2 | 5 | | 2015 | 3 | 2 | 5 | | 2016 | 12 | 3 | 15 | | 2017 | 17 | 3 | 20 | | 2018 | 21 | 5 | 26 | | 2019 | 31 | 6 | 37 | | 2020 | 23 | 5 | 28 | | 2021 | 32 | 5 | 37 | | 2022 | 34 | 0 | 34 | | 2023 | 29 | 3 | 32 | | 2024 | 25 | 7 | 32 | | 2025 | 27 | 6 | 33 | | 2026 | 6 | 0 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Cognitive Dysfunction" by people in Profiles.
-
Gonzalez H, Ridgeway K, Shorer EF, Dastgheyb R, Rajagopal R, Cao Y, Morack R, Hahm E, Weber KM, Rubin LH, French AL. Plasma suPAR and domain-specific cognitive performance in virologically suppressed women with HIV. J Neurovirol. 2026 Jul 08; 32(4).
-
Martens CR, Decker KP, DeConne TM, Sanjana F, Horvat F, Rizzi NA, Awad C, Habash E, Hobson JC, Kramer MK, Armstrong ML, Reisdorph N, Pohlig RT, Lanzi AM, Johnson CL, Cohen ML, Ellison JM. A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment. Alzheimers Dement. 2026 Jul; 22(7):e71605.
-
Ridgeway K, Dastgheyb RM, Easter RE, Shorer EF, Anok A, Tomusange S, Mannarino J, Saylor D, Gisslen M, Zetterberg H, Nakasujja N, Nakigozi G, Paul R, Rubin LH. Cognitive and sensorimotor impairments in virally suppressed people with and without HIV in Uganda: Associations with neurofilament light chain as a biomarker of neuronal injury. J Neurovirol. 2026 Jun 22; 32(4).
-
Carlisle TC, Gunn-Sandell LB, Lippitt WL, Zhu S, Medina LD, Holden SK, Amara AW, Bettcher BM, Carlson NE. Refining the Parkinson's Disease Risk Estimator for Decline In Cognition Tool (PREDICT). Cogn Behav Neurol. 2026 06 01; 39(2):64-73.
-
Konczal L, Enns GM, Gropman AL, Garcia D, Merritt Ii JL, Wilkening G. Emerging neurological and cognitive symptoms in patients with late-onset ornithine transcarbamylase deficiency: a narrative review. Metab Brain Dis. 2026 Mar 13; 41(1).
-
Knopman DS, Koltai D, Laskowitz DT, Becker J, Charvet L, Wisnivesky J, Federman A, Silverstein A, Lokhnygina Y, Pilloni G, Haddad M, Mahncke H, Van Vleet T, Huang R, Cox W, Terry D, Karwowski J, McCray N, Lin JJ, McComsey GA, Singh U, Geng LN, Chu HY, Reece R, Moy J, Arvanitakis Z, Parthasarathy S, Patterson TF, Gupta A, Ostrosky-Zeichner L, Parsonnet J, Kiriakopoulos ET, Fong TG, Mullington J, Jolley S, Shah NS, Morimoto SS, Lee-Iannotti JK, Killgore WDS, Dwyer B, Stringer W, Isache C, Frontera JA, Krishnan JA, O'Steen A, James M, Harper BL, Zimmerman KO. Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trial. JAMA Neurol. 2026 Jan 01; 83(1):49-59.
-
Zarich S, Cole RM, Fairchild K, Spakowicz D, Sparagna G, Madison A, Ni A, Belury MA. Effects of Walnuts on Postprandial Cognitive Function in Adults With Subjective Cognitive Impairment: Protocol for a Randomized Crossover Trial. JMIR Res Protoc. 2025 Dec 19; 14:e82032.
-
Mallah K, Krieg C, Hatchell D, Hamouda N, Roof T, Walterhouse S, Toutonji A, Borucki D, Couch C, Hardiman G, Kobeissy F, Guglietta S, Tomlinson S. Targeted complement inhibition ameliorates the pathological and cognitive outcomes in repetitive mild closed head injury. Signal Transduct Target Ther. 2025 11 20; 10(1):378.
-
Oh ES, Opoku G, Darvish S, Craighead DH, Ostrow A, Rossman MJ, Steele CN, Struemph T, You Z, Seals DR, Chonchol M, Nowak KL. Sex Differences in Dementia and Mild Cognitive Impairment in Nondialysis CKD. Clin J Am Soc Nephrol. 2026 Mar 01; 21(3):389-400.
-
Sanderson-Cimino M, Possin KL, Mungas DM, Paolillo EW, Asken BM, Tsoy E, Jarrott S, Cobigo Y, Saloner R, Casaletto KB, Considine C, Fields JA, Molden J, Rascovsky K, Weintraub S, Wong B, Heuer HW, Forsberg LK, Rojas JC, VandeVrede L, Ljubenkov P, Rabinovici GD, Gorno-Tempini ML, Seeley WW, Miller BL, Boeve BF, Rosen HJ, Boxer AL, Rankin KP, Kramer JH, Staffaroni AM. Development and validation of the TabCAT-EXAMINER: A tablet-based executive functioning battery for research and clinical trials. J Int Neuropsychol Soc. 2025 03; 31(3):242-253.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|